Undecylenic Acid

Undecylenic Acid

SCHEMBL325645

C=CCCCCCCCCC(=O)[O-].[K+]

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Undecylenic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ABCC4 O15439 1/20 0.61
MAPT P10636 1/20 0.61
FABP3 P05413 9/20 0.57
ALDH1A1 P00352 2/20 0.53
LMNA P02545 1/20 0.53
BBOX1 O75936 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Potassium Ion SCHEMBL3921191 1.00 ABCC4 (0.61) ABCC4MAPTFABP3ALDH1A1LMNA
Potassium Ion SCHEMBL4749548 1.00 ABCC4 (0.61) ABCC4MAPTFABP3ALDH1A1LMNA
Undecylenic Acid SCHEMBL1004317 0.95 ABCC4 (0.61) ABCC4MAPTFABP3ALDH1A1LMNA
Lithium Ion SCHEMBL9356507 0.95 ABCC4 (0.61) ABCC4MAPTFABP3ALDH1A1LMNA
Undecylenic Acid SCHEMBL1519053 0.95 ABCC4 (0.61) ABCC4MAPTFABP3ALDH1A1LMNA
SCHEMBL7929595 0.95 ABCC4 (0.61) ABCC4MAPTFABP3ALDH1A1LMNA
Undecylenic Acid SCHEMBL18985294 0.95 ABCC4 (0.61) ABCC4MAPTFABP3ALDH1A1LMNA
Undecylenic Acid SCHEMBL14357975 0.95 ABCC4 (0.61) ABCC4MAPTFABP3ALDH1A1LMNA
SCHEMBL9359899 0.95 ABCC4 (0.61) ABCC4MAPTFABP3ALDH1A1LMNA
SCHEMBL3165049 0.95 ABCC4 (0.61) ABCC4MAPTFABP3ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 491 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240023559-A1 ANTIMICROBIAL LIQUID COMPOSITION AND USE THEREOF AS A PRESERVATIVE ACTIVATOR IN COSMETIC PRODUCTS ROQUETTE FRERES (FR) 2024-01-25 US claimed
EP-4258884-A1 ANTIMICROBIAL LIQUID COMPOSITION AND USE THEREOF AS A PRESERVATIVE ACTIVATOR IN COSMETIC PRODUCTS ROQUETTE FRERES (FR) 2023-10-18 EP claimed
CN-116829124-A Antimicrobial liquid compositions and their use as cosmetic preservative activators 罗盖特公司 2023-09-29 CN claimed
WO-2022122187-A1 ANTIMICROBIAL LIQUID COMPOSITION AND USE THEREOF AS A PRESERVATIVE ACTIVATOR IN COSMETIC PRODUCTS ROQUETTE FRERES (FR) 2022-06-16 WO claimed
US-20190201316-A1 HAIR TREATMENT AGENTS HENKEL AG & CO. KGAA (DE) 2019-07-04 US claimed
CN-109589298-A A kind of artemia eggs ghost dispersion liquid and its preparation process and application 水母娘娘海洋生物科技有限公司 2019-04-09 CN claimed
US-20190099342-A1 COOLING PRODUCT SYMRISE AG (DE) 2019-04-04 US claimed
CN-105638650-B A kind of environmental-friendly dinotefuran micron-emulsion of organic solvent-free and preparation method thereof 南京善思生物科技有限公司 2018-06-01 CN claimed
US-20170151167-A1 HAIR TREATMENT AGENTS HENKEL AG & CO. KGAA (DE) 2017-06-01 US claimed
CN-105638650-A Environment-friendly dinotefuran microemulsion free of organic solvent and preparation method thereof 南京善思生物科技有限公司 2016-06-08 CN claimed
US-20110060099-A1 COMPOSITION HAVING IMPROVED ADHERENCE WITH AN ADDITION-CURABLE MATERIAL AND COMPOSITE ARTICLE INCORPORATING THE COMPOSITION DOW CORNING CORPORATION (US) 2011-03-10 US claimed
US-7858197-B2 Composition having improved adherence with an addition-curable material and composite article incorporating the composition DOW CORNING CORPORATION (US) 2010-12-28 US claimed
US-20100158964-A1 Personal Care Composition Providing Quietness and Softness Enhancement and Articles Using the Same KIMBERLY-CLARK WORLDWIDE, INC. 2010-06-24 US claimed
EP-1706450-B1 A COMPOSITION HAVING IMPROVED ADHERENCE WITH AN ADDITION-CURABLE MATERIAL AND COMPOSITE ARTICLE INCORPORATING THE COMPOSITION DOW CORNING (US) 2009-03-11 EP claimed
US-20080177000-A1 Composition Having Improved Adherence With an Addition-Curable Material and Composite Article Incorporating the Composition DOW CORNING CORPORATION 2008-07-24 US claimed
JP-2007518869-A 2007-07-12 JP claimed
CN-1922253-A A composition having improved adherence with addition-curable material, and composite article incorporating the composition DOW CORNING (US) 2007-02-28 CN claimed
EP-1706450-A1 A COMPOSITION HAVING IMPROVED ADHERENCE WITH AN ADDITION-CURABLE MATERIAL AND COMPOSITE ARTICLE INCORPORATING THE COMPOSITION Dow Corning Corporation (US) 2006-10-04 EP claimed
WO-2005071006-A1 A COMPOSITION HAVING IMPROVED ADHERENCE WITH AN ADDITION-CURABLE MATERIAL AND COMPOSITE ARTICLE INCORPORATING THE COMPOSITION DOW CORNING CORPORATION (US) 2005-08-04 WO claimed
CN-1398903-A Microemulsion synthesis process of metal-containing organic glass JIANG PINGPING (CN) 2003-02-26 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190099342-A1 COOLING PRODUCT TRPA1, TRPV2, NISCH ABCC4 4379/4885MAPT 1951/4885FABP3 1536/4885
US-20170151167-A1 HAIR TREATMENT AGENTS HDAC10, SHH, SGMS1 ABCC4 4195/4885MAPT 671/4885FABP3 2003/4885
US-20190201316-A1 HAIR TREATMENT AGENTS HDAC10, SHH, SGMS1 ABCC4 4195/4885MAPT 671/4885FABP3 2003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.